Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists

Chinese Medical Journal

Volumn 113, Issue 3, 2000, Pages 228-231

  Fu, Jianxin ^a   Chen, Zixing ^a   Cen, Jiannong ^a   Ruan, Changgeng ^a  

^a The First Affiliated Hospital   (China)

Author keywords

Leukemic cells; Multidrug resistance gene; P glycoprotein antagonists

Indexed keywords

COLCHICINE; CREMOPHOR; CYCLOSPORIN A; GLYCOPROTEIN P; RHODAMINE 123; VINCRISTINE;

ARTICLE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMYELOCYTE;

CYCLOSPORINE; GENES, MDR; HUMANS; K562 CELLS; LEUKEMIA; P-GLYCOPROTEIN; RETROVIRIDAE; RHODAMINE 123; TRANSFECTION; VINCRISTINE;

EID: 0034063423     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62: 385-427.
2. Podda S, Ward M, Himelstein A, et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci U S A 1992;89:9676-9680.
3. Schinkel AH, Mayer U, Wagenaar E, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type ( drug-transporting) P-glycoproteins. Proc Natl Acad Sci U S A 1997;94: 4028-4033.
4. Sorrentino BP, McDonagh KT, Woods D, et al. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995;86:491-501.
5. Yang JM, Goldenberg S, Gottesman MM, et al. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res 1994;54:730-737.
6. Licht T, Herrmann F, Gottesman MM, et al. In vivo drug-selectable genes: a new concept in gene therapy. Stem Cells 1997;15: 104-111.
7. Schwarzenberger P, Spence S, Lohrey N, et al. Gene transfer of multidrug resistance into factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection. Blood 1996;87:2723-2731.
8. Hanania EG, Giles RE, KavanaghJ, et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci U S A 1996;93:15346-15351.
9. Aran JM, Gottsman MM, Pastan I. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and β-galactosidase or green fluorescent protein. Cancer Gene Ther 1998;5:195-206.
10. Landowski TH, Gleason-Guzman MC, Dalton WS. Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 1997;89:1854-1861.
11. Bunting KD, Galipeau J, Topham D, et al. Transduction of bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998;92:2269-2279.
12. Matsushita H, Kizaki M, Kobayashi H, et al. Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemia cells. Blood 1998;91:2452-2458.
13. Bezombes C, Maestre N, Laurent G, et al. Restoration of TNF-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J 1998;12:101-109.
14. Havenga M, Hoogerbrugge P, Valerio D, et al. Retroviral stem cell gene therapy. Stem Cells 1997;15:162-179.